Home Care Devices Expected to be the Fastest Growing Application of BioMEMS Devices with a Robust CAGR of 37.4% Between 2016 and 2022 and Touches US$1 Billion Mark by 2022 - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/4rf9jh/biomems_devices) has announced the addition of the "BioMEMS Devices - A Global Market Overview" report to their offering.

BioMEMS devices deployed in hospitals and healthcare facilities are primarily focused on medical screening and diagnostic applications, such as devices that measure point-of-care parameters. Wearable devices that facilitate and assure continuous monitoring without hampering a user's freedom of movement are being bolstered through new opportunities offered by innovative sensors for human biomedical signal acquisition coupled with wireless connectivity and low power solutions.

In addition, greater attention is being accorded to diagnostic MEMS sensors that can assist in performing critical functions, such as cholesterol monitoring, pregnancy monitoring, food allergy detection and DNA analyses. Sensor technologies in several cases provide crucial outcomes and form a major element in the process of assisting in decision-making before obtaining formal clinical intervention and care.

Over the coming years, the functionality of BioMEMS devices/sensor technologies and derivative solutions will maintain an upward trend, which can be attributed to the declining cost of sensor technologies and progressions in infrastructural and information and communications technologies that would cause sensor data to be efficiently aggregated, processed, stored and visualized.

Other factors propelling the rate of development in BioMEMS technologies include increasing demand for understanding and managing personal health and well-being and monitoring of environmental conditions. BioMEMS devices of the future are likely to have greater selectivity and sensitivity, in addition to greater stability and capability in identifying and classifying events that would enable in preventing false alarms.

Key Topics Covered:

1. INTRODUCTION

2. KEY MARKET TRENDS

3. KEY GLOBAL PLAYERS

4. KEY BUSINESS TRENDS

5. GLOBAL MARKET OVERVIEW

Companies Mentioned:

  • All Sensors Corporation
  • Analog Devices Inc
  • Bluechiip Ltd
  • Capitalbio Corporation
  • Debiotech S.A.
  • First Sensor AG
  • Freescale Semiconductor, Inc.
  • Honeywell International Inc
  • Integrated Sensing Systems, Inc
  • Knowles Corporation
  • Micralyne Inc.
  • Omron Corporation
  • Perkinelmer Inc.
  • Silicon Microstructures, Inc.
  • St. Jude Medical, Inc.
  • Stmicroelectronics
  • TE Connectivity Ltd
  • Teledyne Technologies Incorporated

For more information visit http://www.researchandmarkets.com/research/4rf9jh/biomems_devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices